Press Release

08
April
2022
Oxehealth COVID-19 business continuity statement
17
March
2020

Oxehealth’s response to COVID-19

08
April
2022
Oxehealth Follows Up on a Great 2019 With Momentum in Q1 2020
03
April
2020

Oxehealth have signed a number of contracts in Q1 2020, signalling a promising year with significant growth opportunities ahead.

08
April
2022
Oxehealth secures world-first accreditation for its vital signs technology
18
September
2018

The British Standards Institute (BSI) has accredited Oxehealth’s vital signs measurement software as a Class IIa medical device in Europe.

08
April
2022
FDA grants Oxehealth Vital Signs De Novo clearance; Oxehealth launches in the US
31
March
2021

Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product.